In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Small-Cap Biotech M&A, via the Internet

Executive Summary

Robert Naismith, CEO of eMed Securities, a private investment banking firm, has just sold tiny, troubled American biotech firm Cistron to Celltech in the UK--via the Internet. Naismith put a lot of work into building a case that Cistron's science was good, even if its corporate history was less than sterling. Then he e-mailed letters tailored to different types of potential buyers and watched the information he'd posted on his firm's web site get 30,000 hits in the two weeks. EMed intends to keep on leveraging the Internet, not only to promote M&A of small-cap life science companies, but to help those firms attract retail capital. On-line roadshows are on the way, he says.
Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001411

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel